Plans include an AI bioprocess control centre, per reports filed 31 October 2026.
CAPCell will integrate artificial intelligence tools to optimize stem cell manufacturing processes and reduce production losses.
Dr. Manuel Rodríguez Martínez stated the project will establish an AI-enabled center for stem cell manufacturing bioprocess control. Stated objectives are improved cell quality, reduced production losses, and increased treatment accessibility.
No implementation timeline or production target figures were included in the filed reports.
Read with its sources →